Partial agonism at GPCRs is not inherently disadvantageous and can, in some contexts, confer therapeutic benefits
Health Canada's regulation of cosmetics does not require pre-market approval for ingredients with established safety profiles when used in cosmetic products
The plasma concentration profiles of levocarnitine after a slow 3 minute intravenous bolus dose of 20 mg/kg of Levocarnitine were described by a two-compartment model
When AI, a strong ATS, disciplined processes, and a capable internal team come together, the need for agencies disappears quickly
Without treatment, hyperthyroidism can progress to a thyroid storm (thyrotoxicosis)a potentially fatal condition characterized by high fevers, abnormally fast heart rate, nausea, vomiting, shakiness, agitation, and psychosis
Key characteristics: 28 to 90 day beyond-use date from preparation (varies by pharmacy) May or may not contain preservatives Multi-dose vials requiring multiple punctures Potency can vary between batches Different pharmacies produce different quality levels Storage requirements may differ from brand-name The variability between compounding pharmacies is significant